My Lung Health Coach: a 12-week virtual COPD self-management program integrated with your patient portal.
Official title: My Lung Health Coach-A Virtual COPD Self-management Support Program Integrated Into the Electronic Patient Record
Run by Women's College Hospital · NCT07027852 · Data updated 2026-11-12
This program will try a 12-week virtual one-on-one COPD education and self-management support delivered by a certified respiratory educator plus a companion Epic app for adults with COPD who are current or former smokers.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 100 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Women's College Hospital Academic / other |
| Drugs / interventions | prednisone |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | January 15, 2025 |
| Main results expected | October 1, 2025 |
| Study ends | June 5, 2026 |
| Registry record updated | June 19, 2025 |
| Trial ID | NCT07027852 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are adults age 40 or older with COPD confirmed by a WCH respirologist, who are current or former smokers, able to provide consent, and able to download and use the Epic Care Companion app.
✕Probably not a fit
Patients who had a COPD exacerbation in the prior 4 weeks, have clinician-diagnosed asthma, have significant comorbid or terminal illness, are pregnant, or cannot use the Epic Care Companion app are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
My Lung Health Coach (MLHC) delivers six one-on-one virtual sessions over 12 weeks with certified respiratory educators covering COPD basics, smoking cessation, inhaler and oxygen use, physical activity, mental wellness, vaccinations, symptom self-management, nutrition, travel, and long-term planning. A companion app integrated into the Epic Care Companion at Women’s College Hospital allows participants to track progress and complete session-specific activities on phones, tablets, or desktops. The program targets adults aged 40 and older with COPD who are current or former smokers and able to use the patient portal. The study will test the feasibility and effectiveness of combining educator-led virtual sessions with an integrated patient-facing app in a single-center implementation.
Why it matters
Potential benefit: If successful, MLHC could help people with COPD better manage symptoms, improve adherence to therapies, and reduce urgent healthcare visits through structured education and remote support.
How similar studies have gone: Prior telehealth and structured COPD self-management programs have shown promising improvements in self-care, exercise capacity, and reduced healthcare use, although outcomes vary by program and setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Must be deemed to have capacity to provide informed consent; 2. Must sign and date the informed consent form; 3. Stated willingness to comply with all study procedures; 4. Be diagnosed with COPD as per a WCH Respirologist 5. Be 40 years or older 6. Be a current or ex-smoker 7. Preferred but not required: have a history of at least 1 COPD exacerbation (requiring prednisone or antibiotic use, or an urgent healthcare visit of any kind) in the previous 12 months Exclusion Criteria: 1. Experienced a COPD exacerbation in the 4 previous weeks to study enrollment 2. Co-diagnosis of asthma by a WCH Respirologist 3. Significant co-morbidities that could interfere with program participation or terminal illness 4. Unwilling to download and use the Epic Care Companion app and has a unsuitable mobile device to do this 5. Pregnancy
Where it's running
-
Womens College Hospital
Toronto, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Andrew Kouri, MD — Womens College Hospital
- Study coordinator: Andrew Kouri, MD
- Email: andrew.kouri@wchospital.ca
- Phone: (416) 323-6400
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
-
Cognitive load and inhaler technique in COPD
This study tests whether adding a short memory task while using an inhaler makes COPD patients more likely to misuse their inhaler.
-
Balance training after pulmonary rehab for COPD to help steadiness and reduce falls
A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.
-
Continuous vs High-Intensity Interval Exercise in COPD
This study tests whether continuous versus high-intensity interval exercise affects cerebral oxygenation in people with COPD.
-
Biomarker clues for COPD, IPF, and lung cancer
This study tests whether inflammation, immune, genetic, and epigenetic markers at enrollment can explain how COPD, IPF, or lung cancer present and behave, in order to see if these markers can predict outcomes over a year.
-
HRS-9821 Inhalation Suspension for COPD: Safety and Dose Finding in Adults
This study tests whether HRS-9821 inhalation can be safely taken and help people with moderate to severe COPD, and aims to find a reasonable dose.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.